Rescon GG

Product NDC
64543-044
Requested package NDC
64543-044-04
11-digit product format
645430044
Labeler code
64543
Product ID
64543-044_edfe66d3-63a8-100c-e053-2a95a90aba47
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin and Phenylephrine Hydrochloride
Dosage form
LIQUID
Route
ORAL
Labeler
Capellon Pharmaceuticals, LLC
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
1999-01-01
Marketing end
0000-00-00
Substance
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
100 mg/5mL; mg/5mL
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage64543-04464543-044-04DDiscontinued by firm2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
64543-044-04ML - Milliliter64543-044f9420574-d91e-4b9b-8379-dbb2a98b1b5c12012-07-24
64543-044-16ML - Milliliter64543-044bd647251-894a-4d1f-baef-a8a612da2d9612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GUAIFENESINACTIVE INGREDIENT495W7451VQRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
GUAIFENESINACTIVE MOIETY495W7451VQRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3RESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
SORBITOLINACTIVE INGREDIENT506T60A25RRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
SUCROSEINACTIVE INGREDIENTC151H8M554RESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
TRISODIUM CITRATE DIHYDRATEINACTIVE INGREDIENTB22547B95KRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2
WATERINACTIVE INGREDIENT059QF0KO0RRESCON GG (GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE) LIQUID [CAPELLON PHARMACEUTICALS, LLC]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
64543-044-0464543004404118 mL in 1 BOTTLE (64543-044-04) 118 ml1999-01-010000-00-00NoNoCurrent